United Capital Financial Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

United Capital Financial Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,108	Closed	-$240K	–	1273
2021 Q1	$240K	Buy	+1,108	New	+$208K	﹤0.01%	1052
2019 Q3	–	Sell	-1,205	Closed	-$208K	–	1532
2019 Q2	$208K	Buy	+1,205	New	+$208K	﹤0.01%	1356
2017 Q4	–	Sell	-2,376	Closed	-$241K	–	1372
2017 Q3	$241K	Sell	2,376 -53	-2%	-$5.68K	﹤0.01%	1192
2017 Q2	$244K	Sell	2,429 -19	-0.8%	-$2.04K	﹤0.01%	1144
2017 Q1	$296K	Buy	2,448 +336	+16%	+$41.2K	﹤0.01%	1048
2016 Q4	$236K	Buy	2,112 +257	+14%	+$30.9K	﹤0.01%	1120
2016 Q3	$246K	Buy	+1,855	New	+$177K	﹤0.01%	1125

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

United Capital Financial Advisors's GWPH Position: Q2 2021 in Review

United Capital Financial Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,108 shares — an estimated $240K sold.

United Capital Financial Advisors first reported a position in GWPH in Q3 2016 and held it in 7 quarters. The position peaked at $296K in Q1 2017. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

United Capital Financial Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
United Capital Financial Advisors sold 1,108 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $240K.
United Capital Financial Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2016 and held it in 7 quarters.
United Capital Financial Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $296K in Q1 2017.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on United Capital Financial Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.